Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 8/20 | 0.55 |
| ▸ | NFKB2 | Q00653 | 4/20 | 0.55 |
| ▸ | RELA | Q04206 | 4/20 | 0.55 |
| ▸ | JUN | P05412 | 3/20 | 0.55 |
| ▸ | XPO1 | O14980 | 2/20 | 0.49 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | ATF1 | P18846 | 4/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | AHR | P35869 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | GFER | P55789 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16543696 | 0.84 | NFKB1 (0.59) | NFKB1NFKB2RELAJUNXPO1 | |
| SCHEMBL63532 | 0.84 | HPGD (0.58) | NFKB1NFKB2RELAJUNXPO1 | |
| Hydrochloric Acid SCHEMBL10581860 | 0.82 | HPGD (0.56) | NFKB1NFKB2RELAJUNXPO1 | |
| SCHEMBL3909479 | 0.82 | JUN (0.54) | NFKB1NFKB2RELAJUNXPO1 | |
| SCHEMBL16543697 | 0.79 | NFKB1 (0.51) | NFKB1NFKB2RELAJUNXPO1 | |
| SCHEMBL21746957 | 0.79 | NFKB1 (0.55) | NFKB1NFKB2RELAJUNXPO1 | |
| SCHEMBL429969 | 0.79 | NFKB1 (0.46) | NFKB1NFKB2RELAJUNXPO1 | |
| SCHEMBL31469871 | 0.79 | NFKB1 (0.46) | NFKB1NFKB2RELAJUNXPO1 | |
| SCHEMBL3435395 | 0.77 | RAB9A (0.53) | NFKB1NFKB2RELAJUNHPGD | |
| SCHEMBL31391972 | 0.77 | RAB9A (0.53) | NFKB1NFKB2RELAJUNHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180133220-A1 | COMPOUNDS FOR USE IN TREATING ACUTE CORONARY SYNDROME AND RELATED CONDITIONS | VITAE PHARMACEUTICALS, LLC | 2018-05-17 | — | — | US | disclosed |
| US-20180117041-A1 | LIVER X RECEPTOR MODULATORS | VITAE PHARMACEUTICALS, INC. | 2018-05-03 | — | — | US | disclosed |
| US-20170231992-A1 | COMPOUNDS FOR USE IN TREATING ACUTE CORONARY SYNDROME AND RELATED CONDITIONS | VITAE PHARMACEUTICALS, INC. | 2017-08-17 | — | — | US | disclosed |
| US-9707232-B2 | Liver X receptor modulators | VITAE PHARMACEUTICALS, INC. (US) | 2017-07-18 | — | — | US | disclosed |
| US-20170007603-A1 | LIVER X RECEPTOR MODULATORS | VITAE PHARMACEUTICALS, LLC | 2017-01-12 | — | — | US | disclosed |
| US-9416135-B2 | Liver X receptor modulators | VITAE PHARMACEUTICALS, INC. (US) | 2016-08-16 | — | — | US | disclosed |
| US-20160113930-A1 | COMPOUNDS FOR USE IN TREATING RETT SYNDROME | VITAE PHARMACEUTICALS, INC. | 2016-04-28 | — | — | US | disclosed |
| US-20150336963-A1 | LIVER X RECEPTOR MODULATORS | VITAE PHARMACEUTICALS, LLC | 2015-11-26 | — | — | US | disclosed |
| US-20150250787-A1 | COMPOUNDS FOR USE IN TREATING SKIN CANCERS | VITAE PHARMACEUTICALS, INC. | 2015-09-10 | — | — | US | disclosed |
| US-9073931-B2 | Liver X receptor modulators | VITAE PHARMACEUTICALS, INC. (US) | 2015-07-07 | — | — | US | disclosed |
| US-4191686-A | FROM SULFONYL HALIDE SUBSTITUTED PARENT BY AMIDATION WITH AROMATIC DIAMINE, DIAZOTIZING, COUPLING TO KETO SUCCINIC ESTER, CYCLIZING, COUPLING TO REACTIVE MOIETY | CASSELLA AKTIENGESELLSCHAFT (DE) | 1980-03-04 | — | — | US | disclosed |
| US-4126609-A | AZO DYESTUFF WITH A FIBER-REACTIVE GROUP ATTACHED TO A NAPHTHALENE SULPHONIC ACID COMPONENT | BAYER AKTIENGESELLSCHAFT (DE) | 1978-11-21 | — | — | US | disclosed |
| US-4122079-A | Reactive azo dyestuffs from diazotized sulfo-amino naphthalenes and diaminosulfobenzenes | BAYER AKTIENGESELLSCHAFT (DE) | 1978-10-24 | — | — | US | disclosed |
| US-4118382-A | DYES FOR CELLULOSE, WOOL, SILK, POLYAMIDE, AND POLYURETHANE FIBERS | BAYER AKTIENGESELLSCHAFT (DE) | 1978-10-03 | — | — | US | disclosed |
| US-4089895-A | COUPLER FOR AZO DYES | BAYER AKTIENGESELLSCHAFT (DT) | 1978-05-16 | — | — | US | disclosed |
| US-4065446-A | Reactive dyestuffs containing urea alkylene linkage between chromophore and reactive radical | BAYER AKTIENGESELLSCHAFT (DT) | 1977-12-27 | — | — | US | disclosed |
| US-4049704-A | AZO REACTIVE DYES | BAYER AKTIENGESELLSCHAFT (DT) | 1977-09-20 | — | — | US | disclosed |
| US-3989692-A | PHTHALOCYANINE DYES, WOOL, SILK, POLYAMIDES, CELLULOSE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-11-02 | — | — | US | disclosed |
| US-3988310-A | FIBER-REACTIVE DYES; CELLULOSE | BAYER AKTIENGESELLSCHAFT (DT) | 1976-10-26 | — | — | US | disclosed |
| US-3957751-A | WATER-SOLUBLE REACTIVE DYESTUFFS OF THE MONOAZO SERIES CONTAINING AN ACTIVE METHYLENE COUPLING COMPONENT | HOECHST AKTIENGESELLSCHAFT (DT) | 1976-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180117041-A1 | LIVER X RECEPTOR MODULATORS | SLC10A1, NR1H4, NR1H2 | NFKB1 2853/4885NFKB2 2725/4885RELA 3119/4885 |
| US-20150336963-A1 | LIVER X RECEPTOR MODULATORS | SLC10A1, NR1H4, NR1H2 | NFKB1 2853/4885NFKB2 2725/4885RELA 3119/4885 |
| US-20170231992-A1 | COMPOUNDS FOR USE IN TREATING ACUTE CORONARY SYNDROME AND RELATED CONDITIONS | TNNI3, FABP3, TNNT2 | NFKB1 1156/4885NFKB2 1319/4885RELA 1668/4885 |
| US-20160113930-A1 | COMPOUNDS FOR USE IN TREATING RETT SYNDROME | RET, RARS2, RARS1 | NFKB1 4223/4885NFKB2 4188/4885RELA 4843/4885 |
| US-20150250787-A1 | COMPOUNDS FOR USE IN TREATING SKIN CANCERS | TP53, KRT18, VHL | NFKB1 1123/4885NFKB2 1359/4885RELA 1083/4885 |
| US-20180133220-A1 | COMPOUNDS FOR USE IN TREATING ACUTE CORONARY SYNDROME AND RELATED CONDITIONS | TNNI3, FABP3, TNNT2 | NFKB1 1156/4885NFKB2 1319/4885RELA 1668/4885 |
| US-20170007603-A1 | LIVER X RECEPTOR MODULATORS | SLC10A1, NR1H4, NR1H2 | NFKB1 2853/4885NFKB2 2725/4885RELA 3119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.